--Siemens Healthineers is considering strategic options for its diagnostics business, which could be valued at up to $8 billion, with a sale or carve-out among the scenarios being considered, Bloomberg reports, citing unnamed sources.

--The review, which seeks to streamline the German healthcare group's operations, is at an early stage and the company could still opt to keep the assets, but the business would likely attract interest from private-equity groups, according to Bloomberg.

--Siemens Healthineers didn't respond to a request for comment when contacted by Dow Jones Newswires.

Full story: https://shorturl.at/fkpsA

Write to Adria Calatayud at adria.calatayud@dowjones.com

(END) Dow Jones Newswires

November 03, 2023 03:41 ET (07:41 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Siemens Healthineers (TG:SHL)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024 Siemens Healthineers 차트를 더 보려면 여기를 클릭.
Siemens Healthineers (TG:SHL)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024 Siemens Healthineers 차트를 더 보려면 여기를 클릭.